KRAS and colon adenocarcinoma: Moreover, in lung and colon adenocarcinomas, there was no correlation with low expression of the 80 genes and the G12 activating mutation in KRAS, HaRas or NRas mutations, or with other Ras activating mutations, G13 or Q61 [55] (Data File S1).